Validation and reliability test of Chinese language patient-reported impact of symptoms in schizophrenia scale

被引:0
|
作者
Lin, Xiao [1 ]
Tian, Hongjun [2 ,3 ]
Wang, Lina [4 ]
Li, Ranli [4 ]
Ma, Xiaoyan [4 ]
Sun, Yun [4 ]
Cai, Ziyao [1 ]
Ping, Jing [1 ]
Chen, Langlang [1 ]
Zhuo, Chuanjun [1 ,2 ,3 ,4 ,5 ]
Yu, Haiping [1 ]
机构
[1] Wenzhou Seventh Peoples Hosp, Dept Psychiat, Wenzhou, Peoples R China
[2] Nankai Univ, Tianjin Ctr Hosp 4, Key Lab Sensor Informat Proc Abnormal Schi SIPAS L, Affiliated Tianjin Ctr Hosp 4, Tianjin, Peoples R China
[3] Tianjin Med Univ, Tianjin Ctr Hosp 4, Key Lab Sensor Informat Proc Abnormal Schizophreni, Affiliated Tianjin Ctr Hosp 4, Tianjin, Peoples R China
[4] Tianjin Med Univ, Tianjin Anding Hosp, Lab Psychiat Neuroimaging Genet & Comorbid, Tianjin Mental Hlth Ctr, Tianjin, Peoples R China
[5] Tianjin Anding Hosp, Dept Psychiat, Tianjin, Peoples R China
来源
FRONTIERS IN PSYCHIATRY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
validity; reliability; schizophrenia; CL-PRISS; CFA; PANSS;
D O I
10.3389/fpsyt.2023.1158937
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
BackgroundPatient-reported outcomes, or subjective evaluations directly reflecting the patient's views, feelings, and judgments, are now being used to evaluate the outcomes of care and treatment of people with schizophrenia. In this study, we used an updated tool, the patient-reported impact of symptoms in schizophrenia scale (PRISS), translated into Chinese languages to assess the subjective experiences of schizophrenia patients. ObjectiveThis study aimed to test the psychometrics of the Chinese languages PRISS (CL-PRISS). MethodThis study used the Chinese version of PRISS (CL-PRISS), acquired from the harmonized English-language version. A total of 280 patients enrolled in this study were asked to complete the CL-PRISS, the positive and negative syndrome scale (PANSS), and the World Health Organization Disability Assessment Schedule (WHO-DAS). Construct and concurrent validity was tested using the confirmatory factor analysis (CFA) and Spearman correlation coefficient, respectively. The reliability of CL-PRISS was tested using Cronbach's alpha coefficient and the internal correlation coefficient. ResultsConfirmatory factor analysis (CFA) analysis demonstrated three major factors in CL_PRISS: the first factor is productive experiences, the second factor is affective-negative, and the third factor experiences. The factor loadings between items and factors ranged from 0.436 to 0.899 (RMSEA = 0.029, TLI = 0.940, CFI = 0.921). The correlation coefficient between the CL_PRISS and PANSS was 0.845, and between the CL-PRISS and WHO-DAS was 0.886. The ICC of the total CL_PRISS was 0.913, and Cronbach's alpha was 0.903. ConclusionThe Chinese version of the PRISS (CL_PRISS) can be effectively used for assessing the subjective experience of Chinese patients with schizophrenia.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation
    Moreno-Kustner, Berta
    Fabrega-Ruz, Julia
    Luis Gonzalez-Caballero, Juan
    Reyes-Martin, Sara
    Ochoa, Susana
    Romero-Lopez-Alberca, Cristina
    Cid, Jordi
    Vila-Badia, Regina
    Frigola-Capell, Eva
    Salvador-Carulla, Luis
    ACTA PSYCHIATRICA SCANDINAVICA, 2022, 145 (06) : 640 - 655
  • [2] Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia
    Maurino, Jorge
    Sanjuan, Julio
    Maria Haro, Josep
    Diez, Teresa
    Ballesteros, Javier
    PATIENT PREFERENCE AND ADHERENCE, 2011, 5 : 471 - 474
  • [3] Development of Patient-Reported Outcome Scale for Patients with Diabetic Foot and Its Reliability and Validity Test
    Wang, Xuanyu
    Hu, Xiaojie
    Que, Huafa
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 2921 - 2927
  • [4] Validation of the Chinese Version of the Schizophrenia Cognition Rating Scale
    Huang, Kuan-Wei
    Lin, Pao-Yen
    Lee, Yu
    Huang, Yu-Chi
    Hung, Chi-Fa
    Lee, Sheng-Yu
    Chen, Chih-Ken
    Wang, Liang-Jen
    PSYCHIATRY INVESTIGATION, 2022, 19 (07) : 511 - 518
  • [5] Development and validation of the patient-reported outcome scale for chronic kidney disease
    Yu Shi
    Shi Pu
    Hongmei Peng
    Yu Luo
    International Urology and Nephrology, 2024, 56 : 653 - 665
  • [6] Development and validation of the patient-reported outcome scale for chronic kidney disease
    Shi, Yu
    Pu, Shi
    Peng, Hongmei
    Luo, Yu
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (02) : 653 - 665
  • [7] Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale
    Lenderking, William R.
    Atkinson, Mark J.
    Ladd, Mary Kate
    Savva, Yulia
    Sommer, Stephanie
    Sidovar, Matthew
    Hastedt, Claudia
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2024, 8 (01)
  • [8] Reliability of a patient-reported outcome measure in schizophrenia: Results from back-to-back self-ratings
    Takeuchi, Hiroyoshi
    Fervaha, Gagan
    Remington, Gary
    PSYCHIATRY RESEARCH, 2016, 244 : 415 - 419
  • [9] Patient-Reported Outcome Scale for Idiopathic Pulmonary Fibrosis: Development and Validation in China
    Xie, Yang
    Zhang, Peng
    Ren, Jiaming
    Chen, Tao
    Wang, Jiajia
    Li, Jiansheng
    JOURNAL OF EVIDENCE BASED MEDICINE, 2024, 17 (04) : 758 - 770
  • [10] Sex differences in patient-reported outcome measure of psychotic symptoms in schizophrenia
    Vila-Badia, Regina
    Ochoa, Susana
    Fabrega-Ruz, Julia
    Gonzalez-Caballero, Juan Luis
    Romero, Cristina
    Cid, Jordi
    Frigola-Capell, Eva
    Salvador-Carulla, Luis
    Moreno-Kuestner, Berta
    ARCHIVES OF WOMENS MENTAL HEALTH, 2024, 27 (05) : 721 - 729